CMS and Commercial Insurers Extend Coverage of Oncomine Dx Target Test to more than 160 Million U.S. Lives Payors reimburse first NGS, FDA-approved test for non-small cell lung cancer to expedite targeted therapy selection for patients CARLSBAD, Calif., March 19, 2018 /PRNewswire/ — Thermo Fisher Scientific today announced its Oncomine Dx Target Test has been approved for... Read more
Location: Cambridge 16/03/2018 Partnership immediately provides Horizon with deeper access to Chinese diagnostic assay manufacturers and potential OEM agreements as part of stated global leadership strategy Genewell to pursue CFDA approval of Horizon reference standards for broad distribution into Chinese clinical laboratory market Cambridge, UK, and Shenzhen, China, 16 March 2018: Horizon Discovery Group plc... Read more
Thermo Fisher Scientific Announces Plans to Build State-of-the-Art Pharma Services Facility in Rheinfelden (Baden) Germany New site will support complex clinical research and bring more than 200 new jobs to community RHEINFELDEN, Germany, March 16, 2018 /PRNewswire/ — Thermo Fisher Scientific announced today it is expanding its footprint in the European Union and investing $35 million... Read more
HANOI, Vietnam, June 6 /PRNewswire-FirstCall/ -- QIAGEN was featured this week for its efforts to eliminate cervical cancer at the 14th annual Global Summit of Women in Hanoi, Vietnam. CEO Peer Schatz came to this prominent international platform to issue a call to other leaders in business, NGOs and governments to join him and campaign... Read more
Charité — Universitätsmedizin Berlin Joins Thermo Fisher Scientific’s Next-Generation Sequencing Center of Excellence Program Leading oncology research hospital becomes new member to advance Oncomine™ liquid biopsy and immuno-oncology diagnostics BERLIN and CARLSBAD, Calif., March 15, 2018 /PRNewswire/ — Thermo Fisher Scientific has named Charité – Universitätsmedizin Berlin as the newest member of its Next Generation Sequencing... Read more
MINNEAPOLIS, March 14, 2018 /PRNewswire/ — Bio-Techne has released MimEX™ GI, a new product line for generating 3-dimensional (3-D) gastrointestinal tissue on a 2-D surface. 3-D cell culture and organoid models of the gastrointestinal epithelium are quickly being adopted for toxicology, drug discovery, and disease modeling. These more complex models provide a tremendous benefit over cell line- and primary... Read more
MINNEAPOLIS, March 12, 2018 /PRNewswire/ — At the 2018 US HUPO Conference, Bruker (NASDAQ: BRKR) and Evosep announce that they have executed a co-development and co-marketing agreement for the Evosep One chromatography system to work seamlessly with Bruker’s timsTOF Pro ultra-high resolution quadrupole time of flight mass spectrometer. The timsTOF Pro is powered by TIMS... Read more
MAR 12 2018 Hilden, Germany, and San Carlos, CA, March 12, 2018 – QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA), a world leader in providing Sample to Insight molecular solutions, and Natera, Inc. (NASDAQ: NTRA), a leading developer of next-generation sequencing (NGS) assays that include non-invasive prenatal genetic testing and the analysis of circulating tumor... Read more
MAR 05 2018 New artus® assay enables detection of T. vaginalis from a broad range of sample types and expands sexually transmitted infection (STI) menu Germantown, Maryland, and Hilden, Germany, March 5th, 2018 – QIAGEN today announced the European launch of the artus T. vaginalis QS-RGQ Kit, a CE-marked molecular diagnostic test for the qualitative detection of the... Read more